The pivotal trial programs are STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Meet the Author Keith Rowe Keith has been a member of the BrainMD team for the past 7 years
acute inflammatory cell infiltrate(s), focus/foci of acute inflammatory cells
If confirmed, this represents a new diabetes diagnosis that requires discussion with your provider about treatment modifications, monitoring frequency, and potential need for additional therapies beyond GLP-1 medication
It's about enabling people to capitalise on the benefits of the behaviour changes the medication can support
For a significant impact on skin tone and clarity, a course of 8-10 injections is often recommended